Stryker had 23 patents in artificial intelligence during Q4 2023. Stryker Corp’s patents in Q4 2023 focus on improving efficiency and safety in the operating room through innovative technologies. These patents include methods for determining the duration of medical procedures based on imaging data, monitoring surgical workflows to ensure compliance with planned steps, adjusting surgical schedules based on detected milestones, automated detection of non-compliance with surgical protocols, and generating alerts to close doors in the operating room. These technologies aim to enhance operating room management and patient safety during surgical procedures. GlobalData’s report on Stryker gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Stryker Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Stryker grant share with artificial intelligence as a theme is 8% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Devices, systems, and methods for predicting surgical time and optimizing medical procedures and outcomes (Patent ID: US20230410993A1)

The patent filed by Stryker Corp. discloses a method for determining the duration of a medical procedure by analyzing imaging data of a patient's anatomy to predict the procedure's length. Parameters such as B-score, joint-space width, osteophyte position or volume, alignment, or deformity are used to make this prediction. The method involves identifying specific anatomical features, comparing them to predetermined ranges, and outputting the predicted duration on an electronic display. Additionally, the system described in the patent utilizes imaging devices like CT scans to gather data and algorithms to analyze this information, providing outputs such as operating room layouts, staff requirements, and patient post-procedure predictions based on the determined duration.

The patent claims detail various scenarios where the method can be applied, such as determining the duration based on femur B-scores, joint-space width, osteophyte volume, or alignment parameters. It also includes provisions for incorporating prior procedure data, patient-specific information, and clinical data to enhance the accuracy of the predicted duration. The system described in the patent integrates imaging devices, memory storage for relevant data, a controller to analyze parameters and predict durations, and an electronic display to present the results. Overall, the patent aims to streamline medical procedures by leveraging imaging data and predictive algorithms to optimize operating room schedules, staff allocation, and patient outcomes based on anatomical characteristics.

To know more about GlobalData’s detailed insights on Stryker, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.